Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-16 Purchase(A) |
2024-09-17 8:56 pm |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
300,000 | $17 | $5,100,000 | 1,929,806 (Indirect) |
View |
| 2024-09-16 Purchase |
2024-09-16 8:54 pm |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
300,000 | $17 | $5,100,000 | 1,641,891 (Indirect) |
View |
| 2023-09-29 Purchase |
2023-10-03 4:00 pm |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
24,670 | $13.63 | $336,252 | 1,928,503 (Indirect) |
View |
| 2023-09-26 Purchase |
2023-09-28 5:09 pm |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
30,000 | $13.15 | $394,500 | 1,903,833 (Indirect) |
View |
| 2023-09-19 Purchase |
2023-09-21 4:23 pm |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
30,000 | $13.2 | $396,000 | 1,873,833 (Indirect) |
View |
| 2023-09-12 Purchase |
2023-09-13 9:17 pm |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
24,254 | $11.2 | $271,680 | 1,850,333 (Indirect) |
View |
| 2023-07-13 Purchase |
2023-07-17 8:00 pm |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director |
2,941,176 | $17 | $49,999,992 | 988,045 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-19 Exercise |
2024-11-21 6:30 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
160,160 | $0 | 3,371,922 (Indirect) |
View |
| 2024-09-27 Other |
2024-10-01 8:00 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director |
62,146 | $0 | 2,762,837 (Indirect) |
View |
| 2024-09-16 Conversion(A) |
2024-09-17 8:56 pm |
N/A N/A |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
12,635,428 | $0 | 1,929,806 (Indirect) |
View |
| 2024-09-12 Option Award(A) |
2024-09-17 8:56 pm |
N/A 2034-09-11 |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
37,000 | $0 | 1,929,806 (Indirect) |
View |
| 2024-09-16 Conversion |
2024-09-16 8:54 pm |
N/A N/A |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
12,635,428 | $0 | 1,641,891 (Indirect) |
View |
| 2024-09-12 Option Award |
2024-09-16 8:54 pm |
N/A 2034-09-11 |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
37,000 | $0 | 1,641,891 (Indirect) |
View |
| 2024-09-11 Option Award |
2024-09-13 4:55 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
275,000 | $23 | 3,212,082 (Indirect) |
View |
| 2024-09-11 Option Award |
2024-09-13 4:55 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
160 | $23,000 | 3,212,082 (Indirect) |
View |
Ownership |
2024-09-12 9:41 pm |
N/A N/A |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
0 | $0 | 1,592,806 (Indirect) |
View |
Ownership |
2024-09-06 5:07 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
0 | $0 | 19,662,752 (Indirect) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:05 pm |
N/A 2034-06-26 |
Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director |
21,000 | $0 | 21,000 (Indirect) |
View |
| 2024-06-05 Option Award |
2024-06-07 8:00 pm |
N/A 2034-06-05 |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director |
20,740 | $0 | 20,740 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 7:57 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director |
11,000 | $0 | 11,000 (Indirect) |
View |
| 2024-05-14 Option Award |
2024-05-16 4:10 pm |
N/A 2034-05-14 |
Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director |
22,646 | $0 | 22,646 (Indirect) |
View |
| 2024-04-25 Exercise |
2024-04-25 4:55 pm |
N/A N/A |
Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
3,730,672 | $0 | 5,176,222 (Indirect) |
View |
| 2024-04-01 Other |
2024-04-01 6:21 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director |
58,857 | $0 | 2,880,551 (Indirect) |
View |
| 2024-03-28 Other |
2024-04-01 5:44 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
498,765 | $0 | 9,006,126 (Indirect) |
View |
| 2024-01-29 Other |
2024-01-31 4:31 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director |
943,695 | $0 | 1,046,027 (Indirect) |
View |
| 2024-01-22 Option Award |
2024-01-24 7:02 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
834,334 | $12 | 3,595,170 (Indirect) |
View |
| 2024-01-22 Option Award |
2024-01-24 7:02 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
832,333 | $12 | 3,595,170 (Indirect) |
View |
| 2023-12-29 Other |
2023-12-29 5:00 pm |
N/A N/A |
Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
3,841,518 | $0 | 5,485,719 (Indirect) |
View |
| 2023-12-07 Option Award |
2023-12-11 5:41 pm |
N/A N/A |
Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
16,667 | $600 | 16,667 (Indirect) |
View |
| 2023-11-24 Conversion |
2023-11-28 4:05 pm |
N/A N/A |
Spyre Therapeutics Inc. | AGLE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
3,521,367 | $0 | 4,250,938 (Indirect) |
View |
| 2023-09-11 Option Award |
2023-09-13 9:17 pm |
N/A 2033-09-10 |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
6,500 | $0 | 1,850,333 (Indirect) |
View |
Ownership |
2023-09-13 8:55 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
0 | $0 | 1,819,579 (Indirect) |
View |
| 2023-07-13 Option Award |
2023-07-17 8:00 pm |
N/A 2033-07-13 |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director |
95,516 | $0 | 988,045 (Direct) |
View |
Ownership |
2023-06-30 5:32 pm |
N/A N/A |
Aeglea BioTherapeutics Inc. | AGLE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
0 | $0 | 536,284,540 (Indirect) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:54 pm |
N/A 2033-06-14 |
Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director |
20,000 | $0 | 20,000 (Indirect) |
View |
| 2022-06-08 Option Award |
2022-06-10 07:30 am |
N/A 2032-06-08 |
Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director |
12,500 | $0 | 12,500 (Indirect) |
View |
| 2021-06-03 Option Award |
2021-06-16 6:34 pm |
N/A 2031-06-03 |
Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 5:40 pm |
N/A 2031-02-04 |
Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-10-27 Option Award |
2020-10-29 5:16 pm |
N/A 2030-10-26 |
MIRAGEN THERAPEUTICS INC. | MGEN | Kiselak Tomas Director |
24,000 | $0 | 24,000 (Direct) |
View |